Search Results - "Monte Boquet, E"

Pilot evaluation of home delivery programme in haemophilia by Megías‐Vericat, J. E., Monte‐Boquet, E., Martín‐Cerezuela, M., Cuéllar‐Monreal, M. J., Tarazona‐Casany, M. V., Pérez‐Huertas, P., Bonanad, S., Poveda‐Andrés, J. L.

“…Summary What is known and objectives Most of the clotting factor (CF) dispensations to haemophiliac patients are centralized in a few haemophilia treatment…”
Get full text

Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists by Herranz-Pinto, P, Figueras Nart, I, Monte-Boquet, E, Tortajada Goitia, B

“…Managing atopic dermatitis, one of the most common dermatologic conditions, is often challenging. To establish consensus on recommendations for responding to…”
Get full text

Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia by Megías-Vericat, J.E., Bonanad Boix, S., Haya Guaita, S., Aguilar Rodríguez, M., Viciano Delibano, E., Monte-Boquet, E., Cid Haro, A.R., Pérez-Alenda, S., Palanques-Pastor, T., Bosch, P., Saubí-Cañete, B., Pérez-Rambla, C., Pérez-Sádaba, F.J., Poveda Andrés, J.L.

“…•PROs evaluation help to evaluate treatment strategies based on patient's needs.•An app was designed including PROs related with pain, bleeding and…”
Get full text

[Translated article] Improving the Management and Follow-up of Atopic Dermatitis: A Delphi Process Report of Consensus Between Hospital Dermatologists and Pharmacists by Herranz-Pinto, P., Figueras Nart, I., Monte-Boquet, E., Tortajada Goitia, B.

“…Managing atopic dermatitis, one of the most common dermatologic conditions, is often challenging. To establish consensus on recommendations for responding to…”
Get full text

Expert consensus on the persistence of biological treatments in moderate‐to‐severe psoriasis by de la Cueva Dobao, P., Notario, J., Ferrándiz, C., López Estebaranz, J.L., Alarcón, I., Sulleiro, S., Borrás, J., Daudén, E., Carrascosa, J.M., Sánchez Carazo, J.L., Monte Boquet, E., Puig, L.

“…Background Treatment persistence is becoming a useful measure to evaluate long‐term effectiveness and safety of biological therapies in real‐world settings…”
Get full text

4CPS-251 Hereditary angioedema: impact of the burden of disease in Spain by Monte Boquet, E, José, CB, Navarro Brugueras, M, Escobar Oblitas, AD, Caballero Molina, MT, Smith Flotz, S

“…Background and ImportanceHereditary angioedema (HAE) is a rare disease with a negative impact on patients' quality of life. Understanding the patient pathway…”
Get full text

Treatment Persistence and Safety of Apremilast in Psoriasis: Experience With 30 Patients in Routine Clinical Practice by Sahuquillo-Torralba, A., de Unamuno Bustos, B., Rodríguez Serna, M., Monte Boquet, E., Botella Estrada, R.

“…[Display omitted] Apremilast is a phosphodiesterase-4 inhibitor taken orally. Little information about its use in routine clinical practice is available. We…”
Get full text

Experiencia clínica con los cannabinoides en la terapia de la espasticidad en la esclerosis múltiple by Lorente Fernández, L, Monte Boquet, E, Pérez-Miralles, F, Gil Gómez, I, Escutia Roig, M, Boscá Blasco, I, Poveda Andrés, J.L, Casanova-Estruch, B

“…Resumen Introducción La espasticidad es un síntoma muy frecuente entre los pacientes con esclerosis múltiple (EM). El objetivo del presente estudio es evaluar…”
Get full text

Anidulafungin-Induced Alopecia by Ruiz-Ramos, J., Salavert-Lleti, M., Monte-Boquet, E., Lorente-Fernández, L., Gil-Gómez, I., Poveda-Andrés, J. L.

“…Objetive: To report a case of a woman in whom alopecia appeared after several months of treatment with anidulafungin. Case Summary: A 34-year-old woman with…”
Get full text

6ER-020 Social authorities concerning #hospitalpharmacy on twitter by Montero Delgado, JA, De Pourcq, JT, Monte Boquet, E, Martinez Sesmero, JM, Merino Alonso, FJ

“…BackgroundTwitter has become a useful digital tool for the hospital pharmacy (HP) community.Social Authority Score (SAS) is a Twitter influence scale (1–100)…”
Get full text

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis by Lorente Fernández, L, Monte Boquet, E, Pérez-Miralles, F, Gil Gómez, I, Escutia Roig, M, Boscá Blasco, I, Poveda Andrés, J L, Casanova-Estruch, B

“…Spasticity is a common symptom among patients with multiple sclerosis (MS). This study aims to assess the effectiveness and safety of the combination of…”
Get more information

P365 Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice by Aguas, M., Bosό, V., Navarro, B., Marqués-Miñana, M.R., Bastida, G., Beltrán, B., Iborra, M., Monte-Boquet, E., Poveda-Andrés, J.L., Nos, P.

Get full text

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis by Lorente Fernández, L., Monte Boquet, E., Pérez-Miralles, F., Gil Gómez, I., Escutia Roig, M., Boscá Blasco, I., Poveda Andrés, J.L., Casanova-Estruch, B.

“…Spasticity is a common symptom among patients with multiple sclerosis (MS). This study aims to assess the effectiveness and safety of the combination of…”
Get full text

Salud 2.0: nuevas herramientas de comunicación para el ejercicio profesional de la farmacia hospitalaria by Fernández Lisón, L.C., Juárez Giménez, J.C., Monte Boquet, E.

Get full text

EE254 Biosimilars Impact on the Rheumatoid Arthritis Treatment: A Cost-Effectiveness Model from Spanish National Healthcare System Perspective by Fernandez Santos, JM, Merino-Bohórquez, V, Monte Boquet, E, González Galán, R, Romero de la Cruz, E, Singh, MK, Sharma, V, Borrás Blasco, J

Get full text

EE142 Cost-Effectiveness Analysis of Biosimilars Based Treatment Sequences for Moderate-to-Severe Crohn Disease in Spain by Fernandez Santos, JM, Monte Boquet, E, Borrás Blasco, J, Romero de la Cruz, E, González Galán, R, Singh, MK, Sharma, V, Merino-Bohórquez, V

Get full text

Impact of Adherence on Subcutaneous Interferon Beta-1a Effectiveness Administered by Rebismart® in Patients with Multiple Sclerosis by Edo-Solsona, M, Monte-Boquet, E, Casanova-Estruch, B, Poveda-Andrés, J

Get full text

PND57 - Impact of Adherence on Subcutaneous Interferon Beta-1a Effectiveness Administered by Rebismart® in Patients with Multiple Sclerosis by Edo-Solsona, M, Monte-Boquet, E, Casanova-Estruch, B, Poveda-Andrés, J

Get full text

Líneas de mejora asistencial entre dermatólogos y farmacéuticos hospitalarios para el manejo y seguimiento de la dermatitis atópica: consenso Delphi by Herranz-Pinto, P., Figueras Nart, I., Monte-Boquet, E., Tortajada Goitia, B.

Get full text

4CPS-175 Medication regimen complexity index among solid organ transplant patients in a tertiary hospital by Fernandez-Sanchez, M, Costa-Navarro, A, Monte-Boquet, E, Cuellar-Monreal, MJ, Tarazona-Casany, MV, García-Robles, A, Guerrero-Hurtado, E, Ferrada-Gascon, A, Ballesta-Lopez, O, Iglesias-Gomez, R, Poveda-Andres, JL

“…Background and importanceComplex medication regimens (MR) are associated with worse treatment adherence. The Medication Regimen Complexity Index (MRCI) is a…”
Get full text